CVS Health Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss decreased by 26.1% to $332.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 26.7%, from $453.00M to $332.00M. Over 4 years (FY 2020 to FY 2024), Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss shows an upward trend with a 183.1% CAGR.
other_debt_securities_available_for_sale_unrealized_loss_2eb75f| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $32.00M | $55.00M | $106.00M | $726.00M | $1.52B | $2.23B | $1.84B | $1.39B | $1.43B | $1.74B | $836.00M | $873.00M | $863.00M | $453.00M | $707.00M | $547.00M | $449.00M | $332.00M |
| QoQ Change | — | +71.9% | +92.7% | +584.9% | +108.7% | +46.9% | -17.3% | -24.3% | +2.9% | +21.1% | -51.8% | +4.4% | -1.1% | -47.5% | +56.1% | -22.6% | -17.9% | -26.1% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | +91.9% | -5.4% | -22.0% | -54.6% | -37.3% | -39.8% | -73.9% | -15.4% | -37.3% | -48.0% | -26.7% |